Smartphone AI app to track thyroid eye disease during treatment
Part of Eyes & vision, Genetic & congenital, Hormones & metabolism, Immune system & allergy clinical trials.
This study tests whether a smartphone app using artificial intelligence can help you and your doctor track changes in your thyroid eye disease while you're receiving non-surgical treatment like steroids or biologic therapy. The app lets you take photos and report symptoms from home each week.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older with thyroid eye disease (a condition where the eyes become inflamed due to thyroid problems)
- You are starting non-surgical treatment for thyroid eye disease, such as IV steroids, oral steroids, radiation, or biologic drugs
- You have your own smartphone and can use an app to take facial photos and answer symptom questions at least once per week
- You can attend baseline and follow-up clinic visits with your eye doctor during your treatment course
- You do not have severe eyelid or facial deformities that would prevent clear photos for the AI analysis
- You have not had eye, eyelid, or orbital surgery in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new medicine called MHB018A can reduce swelling and inflammation in thyroid eye disease (TED)—a condition where the immune system attacks tissues around the eyes, causing them to swell, bulge, and become uncomfortable. Researchers will compare MHB018A to placebo (a fake medicine) to see if it helps improve symptoms and appearance.
This study tests a new medication called GenSci098 for people with active thyroid eye disease. It aims to reduce eye symptoms like redness, swelling, and bulging, and improve quality of life.
This trial tests a new drug called MHB018A for chronic thyroid eye disease (TED)—a condition where the eyes become inflamed and swollen due to thyroid problems. The study aims to see if this treatment can reduce eye inflammation and improve symptoms in people who have had TED for over a year.
This study uses MRI scans of the eye area to better understand and classify thyroid eye disease (TED). It aims to help doctors predict outcomes and personalize treatment. You may be eligible if you have stable TED or are a healthy volunteer.
This study offers continued treatment with MHB018A for patients with thyroid eye disease (swelling and bulging of the eyes from thyroid problems) who either didn't improve enough after 24 weeks of treatment or whose symptoms came back. The goal is to see if more treatment can help reduce eye bulging and other symptoms.
This study uses eye tracking to compare how people with thyroid eye disease move their eyes and pay attention to visual cues. It may help researchers understand eye movement problems better.
Hear when a new Thyroid Eye Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.